Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Wilber

Podiatrist, Primary Podiatric Medicine Bettendorf, IA Doctor of Podiatric Medicine

NPI 1114904257 CMS profile 141395

2332 Cumberland Square Dr, Bettendorf, IA 52722

Open in the dashboard

General payments

$62,707

208 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Wilber of Bettendorf, IA is reported in the CMS Open Payments database as having received $62,707 across 208 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Podiatrist, Primary Podiatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $769 18
2024 General $1,976 27
2023 General $744 15
2022 General $18,120 48
2021 General $16,352 31
2020 General $1,098 11
2019 General $23,648 58

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Wilber
  • Podiatrist, Primary Podiatric Medicine median
  • Middle half of Podiatrist, Primary Podiatric Medicine
  • National median

In program year 2025, general payments to Matthew Wilber were reported at $769. Among 368 Podiatrist, Primary Podiatric Medicine profiles paid that year, the median was $232 and the middle half received between $88 and $586.

Show as a table
Year Matthew Wilber Podiatrist, Primary Podiatric Medicine median Middle half National median
2019 $23,648 $166 $51–$513 $163
2020 $1,098 $108 $33–$249 $114
2021 $16,352 $147 $52–$377 $132
2022 $18,120 $188 $66–$551 $149
2023 $744 $195 $70–$509 $160
2024 $1,976 $209 $59–$508 $164
2025 $769 $232 $88–$586 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $32,813 69 payments
  2. Osiris Therapeutics Inc. $12,931 26 payments
  3. Inari Medical, Inc. $11,946 21 payments
  4. Stryker Corporation $2,141 35 payments
  5. Treace Medical Concepts, Inc. $870 17 payments
  6. ConvaTec Inc. $664 13 payments
  7. Kerecis Limited $615 6 payments
  8. Organogenesis Inc. $226 7 payments
  9. DePuy Synthes Sales Inc. $165 2 payments
  10. MedShape, Inc. $66 1 payment
  11. Other $270 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $36,650 21 payments
  2. Travel and Lodging $9,826 40 payments
  3. Consulting Fee $9,750 6 payments
  4. Food and Beverage $6,481 141 payments
Products named General payments · program years 2019–2025
  1. GRAFIX PL $21,264 35 payments
  2. STRAVIX Extremities & Limb Restoration $21,189 32 payments
  3. GRAFIX Other Advanced Wound Management $21,189 32 payments
  4. GRAFIX Other Advanced Wound Management $20,195 41 payments
  5. GrafixPL $19,229 38 payments
  6. CT THROMBECTOMY SYSTEM KIT $12,393 20 payments
  7. Stravix Other Advanced Wound Management $12,010 37 payments
  8. FLOWTRIEVER CATHETER, S $11,393 18 payments
  9. GRAFIX XC $5,894 6 payments
  10. STRAVIX PL $5,495 9 payments
  11. Other $25,338 167 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

152

Median for Podiatry: 160

Drug cost

$1,934

Median for Podiatry: $2,368

Branded share of claims

13.8%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciclopirox Generic 18 $590
Ketoconazole Generic 19 $356
Ciclopirox Ciclopirox Olamine Brand 21 $302
Terbinafine Hcl Generic 18 $289
Gabapentin Generic 24 $200
Cephalexin Generic 20 $167
Ibuprofen Generic 12 $24
Meloxicam Generic 20 $6

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$124,583

Medicare's payments for the services billed

Medicare patients

470

Average age 77

Services billed

2,295

261 women, 209 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Diabetes 42%
Chronic kidney disease 37%
Ischemic heart disease 35%
Atrial fibrillation 23%
Depression 22%
COPD 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

208 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Primary Podiatric Medicine in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record